
A new international Diabetes Data Rights Charter advocates for individuals with diabetes to gain far greater control over the health data produced by their 24/7 monitoring devices. This initiative addresses rising concerns regarding data ownership in the digital healthcare sector, particularly focusing on the vast amounts of personal health data generated by smart medical devices.
The charter is the result of an 18-month international collaboration involving individuals with diabetes, healthcare professionals, researchers, and patient advocates. It aims to resolve data ownership issues related to smart medical devices, responding to a growing concern at the heart of digital healthcare: who owns the data produced by these devices?
Data Ownership Issues in Diabetes Technology
Devices such as continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems generate vast amounts of highly personal health data. However, individuals with diabetes often face restricted access to this data and have limited control over its collection, sharing, and usage. Despite these devices significantly improving the quality of life for people with diabetes globally, questions regarding data access and control remain unresolved.
Users frequently lack complete access to their data and are often unaware of how medical device companies utilize it. This lack of transparency and control has sparked a need for clearer guidelines and rights for individuals with diabetes.
Core Principles of the Charter
- Data Access: Individuals with diabetes should be able to access their real-time data safely and securely, in a usable format, at any time and from any location. This ensures they can make informed decisions about their health.
- Privacy and Security: Diabetes data must be stored and transferred with privacy and security in mind, protecting sensitive health information from unauthorized access.
- Benefits and Interests: The needs and interests of those most impacted by the data should always take priority, ensuring that data usage aligns with the well-being of individuals with diabetes.
- Choice and Control: Individuals should have the ability to provide meaningful consent regarding what data is shared, with whom, and for what purposes, avoiding ‘bundled’ or ‘coerced’ consent practices.
- Accountability and Transparency: All parties involved must be transparent and accountable for how diabetes data is collected, stored, and utilized, supporting trust in the healthcare system.
The charter also highlights concerns related to ‘bundled’ or ‘coerced’ consent, where users must agree to extensive data-sharing arrangements to access essential device functions. Lengthy terms and conditions often hinder understanding of how data is used, leading to calls for greater transparency in product and algorithm development.
Practical Implications and Responses
Dexcom, a leading CGM manufacturer, faced legal action and public criticism when it required users to accept updated terms or stop using the app. This incident shows the prevalence of such practices in connected devices, where essential functionality is tied to continuous data sharing with manufacturers. If users withdraw consent, they may lose access to critical features, leaving them with no meaningful alternative.
Dr. Shane O’Donnell, a research fellow at University College Dublin, co-lead of the charter project, and someone who lives with diabetes, emphasized the importance of data control: “What episodes like Dexcom reveal is that people care intimately about the data they rely on to make life-or-death decisions every single day.” The charter helps articulate these concerns and challenges the healthcare system to adopt more patient-centric data practices.
Tim Street, a type 1 diabetes blogger, shared his experience: “Until about 10 years ago, my records were mine: pen, paper, and whatever I chose to write down. CGMs and apps have dramatically improved my life, but I’ve lost the ability to look back at the granular data. Access to my data in the format I want is one of the many reasons why this Charter is important to me.”
Your questions, but not your email details, will be shared with OpenAI and retained for 30 days in accordance with their terms. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions.
Leave a Reply